Eton Pharmaceuticals, Inc.

Ownership Transactions Reported by 10 Insiders

Symbol: ETON on Nasdaq
Industry: Pharmaceutical Preparations
Location: 21925 W. Field Parkway, Suite 235, Deer Park, IL

Insiders trading volume in the past year

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+118K	100%	$4.98	+$585K
Sells	0
Net	+1	+118K	100%		+$585K

Showing 1 to 3 of 3 entries

Eton Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Opaleye Management Inc.	10%+ Owner	$22.1M	+$585K	+2.72%	Oct 23, 2024
Sean Brynjelsen	President & CEO, Director	$575K			Jan 3, 2025
Norbert G. Riedel	Director	$563K			Jan 3, 2025
James R. Gruber	Chief Financial Officer	$207K			Jan 3, 2025
David Krempa	Chief Business Officer	$207K			Jan 3, 2025
Ipek Erdogan-Trinkaus	Chief Commercial Officer				Dec 2, 2024
Charles J. Casamento	Director				Jan 3, 2025
Paul V. Maier	Director				Jan 3, 2025
Jennifer McKie Adams	Director				Jan 3, 2025
Wilson Troutman	CFO and Secretary				Feb 7, 2022

Recent Insider Transactions by Companies or Individuals for Eton Pharmaceuticals, Inc.

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.